Spica Therapeutics identifies and selectively targets disease-driving macrophage subsets to transform outcomes in oncology, fibroinflammatory and other chronic diseases
Spica Therapeutics identifies and selectively targets disease-driving macrophage subsets to transform outcomes in oncology, fibroinflammatory and other chronic diseases.